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Objectives: To map access to depot medroxyprogesterone acetate (DMPA) from licensed chemical sellers (LCS);
to estimate the proportion of women of reproductive age in areas with access; and to examine affordability
and variability of costs. Methods: A geospatial analysis was conducted using data collected from 298 women
who purchased DMPA from 49 geocoded LCS shops in the Amansie West and Ejisu-Juabeng districts of Ghana
from June 4 to August 31, 2012. The women reported on cost and average distance traveled to purchase
DMPA. Results: In Amansie West, 21.1% of all women of reproductive age lived within average walking distance
and 80.4% livedwithin average driving distance of an LCS. In Ejisu-Juabeng, 41.9% and 60.1% ofwomen livedwith-
in average walking and driving distance, respectively. Distribution of affordability varied across each district.
Conclusions: Access to LCS shops is high, and training LCS to administer DMPA would increase access to family
planning in Ghana, with associated time and cost savings.
© 2015 Published by Elsevier Ireland Ltd. on behalf of International Federation of Gynecology and Obstetrics. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Ghana is largely on track to meet the United Nations Millennium
Development Goals [1]; however, maternal health indicators, including
the use of family planning, are not improving as quickly as other indica-
tors. For example, the proportion ofmarriedwomen usingmodern con-
traception increased from 19% in 2003 to just 23% in 2011, while the
unmet need for family planning is 26% [2]. In addition, the total fertility
rate has remained almost unchanged in the past 10 years, decreasing
from 4.4 births per woman in 1998 to 4.0 births per woman in 2008 [3].
An injectable contraceptive, such as depotmedroxyprogesterone ac-
etate (DMPA), is the most popular family planning method in Ghana,
used by 9% of all married women [2]. Nevertheless, this method cannot
be administered outside of health facilities because prescription and
administration by a qualiﬁed medical professional (doctor, nurse, or
midwife) is required.
Ghana has a critical shortage of trained health workers with only 11
per 10 000 population; indeed, this number falls far short of current
WHO recommendations of at least 23 per 10 000 [4]. Furthermore,ealth at Georgetown University,
20009, USA. Tel.: +1 202 687
ealth atGeorgetownUniversity,
behalf of International Federation ofthere is an urban–rural disparity in the distribution of health workers
who can provide injectable family planning methods. Health facilities
where DMPA can be administered are often under-staffed, suffer from
lack of stock, and are not always accessible, particularly in rural areas.
Other countries have addressed these barriers by allowing provision
of DMPA from community health workers [5–7], and through the use of
non-pharmacy private-sector drug shops, where people in many coun-
tries receive their ﬁrst-line health care [8–11].
Licensed chemical seller (LCS) shops are ubiquitous in Ghana, with
over 9200 registered nationally (J. Nyoagbe, personal communication,
August, 2013), compared with 3217 registered health facilities [12]. As
privately owned businesses, LCS shops have incentives to meet the
needs of their customers. Consequently, they are open for longer, have
shorter waiting times, are perceived to have friendlier staff, and are
less likely to experience lack of stock than health facilities [9]. Further-
more, LCS in Ghana previously demonstrated that, with appropriate
training, theywere capable of selling prescription anti-malarial medica-
tions and referring complicated cases to health facilities during theMo-
bilize Against Malaria project [13].
A previous study implemented by FHI 360 and conducted in the
Ejisu-Juabeng and Amansie West districts of the Ashanti region of
Ghana found that training LCS to safely sell DMPA and refer women to
a qualiﬁed provider for the injection could increase access to this
contraceptive method [14]. In all, 56% of women purchasing DMPA
from LCS were new family planning users, and nearly all of them re-
ceived the injection at the health facility to which they were referredGynecology and Obstetrics. This is an open access article under the CC BY-NC-ND license
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collected as part of this study, allowing the results to be analyzed
geospatially.
The use of geographic information systems (GIS) for geospatial
analysis is gaining popularity, and is recognized as a public-health tool
with many applications [15]. Nevertheless, this approach remains
underutilized. GIS applications allow outcomes to be demonstrated
visually, and have frequently been used in disease surveillance and
treatment programs [16–18], and to examine issues of equity and access
to health facilities [19–22].
Many studies have assessed strategies to improve access to family
planning services [23–27]; however, spatial examination of such inter-
ventions is lacking. The use of GIS has been limited to broad issues sur-
rounding reproductive and maternal health, such as access to services
and facilities [28–30]. Although some studies have examined access to
family planning using GIS technologies [31–35], this approach is often
used to incorporate spatial statistics into predictive models [31,33],
rather than to create visual maps to aid in translating research results
to practice. To date, geospatial analysis of access to drug shops has fo-
cused on the provision of anti-malarial medication [36,37], and the
use of such analysis to measure affordability of family planning inter-
ventions is not common practice.
The present study aimed to conduct geospatial analyses of the re-
sults obtained in the parent study [14], and thereby aid evaluation of
the program’s impact and inform stakeholder decisions for future
scale-up. The present study had two key objectives: (1) to use GIS to
identify andmap the geographic areaswherewomenmight have access
to DMPA from a trained LCS based on the average travel distance, and
estimate the proportion of women of reproductive age in those areas;
and (2) to examine the affordability of accessing DMPA from LCS
shops and model spatial variability of costs.
2. Materials and methods
2.1. Survey data
A geospatial analysis was conducted using data previously reported
by Lebetkin et al. [14]. Approval for the parent study was obtained from
the Protection of Human Subjects Committee, FHI 360, Durham, NC,
USA, and the Ghana Health Services Health and Research Development
Division, Ethical Review Committee, Accra, Ghana. All participants pro-
vided written informed consent at the time of purchasing DMPA.
Consent was conﬁrmed verbally at interview, whichwas conducted ap-
proximately 2–4weeks after purchase to allow time to receive the injec-
tion. Participantswere compensatedwithmobile phone credit valued at
2.00 Ghanaian cedis (approximately US $1.00).
Full details of the original methods are available elsewhere [14]. Brief-
ly, from June to January, 2013, LCS from the Amansie West (n= 75) and
Ejisu-Juabeng (n = 29) districts were trained to sell DMPA (Depo-
Provera; Pﬁzer, New York, NY, USA) and refer users to health facilities to
receive the injection. These 104 LCS were recruited from the group of
144 LCS who had participated in the Mobilize Against Malaria program
[13], and so did not represent a census of all LCS in these two districts. A
subset of LCS (n=49)was randomly selected to consent family planning
users (up to 10 per LCS) to participate in structured phone interviews
about their experience purchasing DMPA and receiving the injection. Eli-
gible users of these services were aged 18–49 years and had access to a
telephone. Interviews were conducted among 237 womenwho had pur-
chased DMPA from LCS shops in Amansie West (n= 40) and 61 women
who had purchased DMPA from LCS shops in Ejisu-Juabeng (n= 9) dur-
ing the period June 4 to August 31, 2012. The sample size was based on
numbers that are meaningful to local decision makers; there was no for-
mal hypothesis tested for the parent study.
Questions posed to users relevant to the present geospatial analysis
related to distance traveled and costs associated with the purchase of
DMPA from the LCS. Users self-reported distance traveled and mode oftransport to the LCS shop where they purchased DMPA, and to the
health facility where they received the injection. They also reported
total costs associated with receiving DMPA, which included traveling
to the LCS shop and the health facility, purchasing DMPA, and receiving
the injection. Owing to unknown response or non-response to relevant
interview questions, the sample sizewas reduced from 298 to 291 users
for the distance analysis, and from 298 to 296 users for the cost analysis.
User responses were linked to the LCS shops where DMPA was pur-
chased. No home addresses were collected. All participating LCS shops
and referral health facilities were geocoded. Hand-held global position-
ing system devices were used to collect longitude and latitude in deci-
mal degrees at these locations with accuracy within 5 m.
2.2. Geospatial analysis
Global positioning system data were combined with the interview
data and displayed on maps. Additional external data was used for the
analysis and creation of these maps. The spatial distribution of women
of reproductive age was accessed from AfriPop, a project with datasets
licensed under Creative Commons Attribution 4.0 International License,
which used Ghana Statistical Service 2000 census data and a combina-
tion of growth rates to estimate the 2010 distribution at a spatial reso-
lution of 100 m [29]. Administrative boundaries were downloaded
from the Centre for Remote Sensing and Geographic Information
Services, University of Ghana-Legon, Accra. Owing to redistricting
that had occurred in 2008, some LCS shops fell outside of the current
district boundaries. The road network dataset was produced with data
from OpenStreetMap (www.openstreetmap.org). Spatial layers were
projected into WGS 1984, UTM Zone 30S, and all geospatial analysis
was completed using ArcGIS version 10.0 (Esri, Redlands, CA, USA).
The proportion of women of reproductive age within the mean dis-
tance traveled to the LCS shop to purchase DMPA, as well as within a
range of distances (1–5 km) to both LCS shops and health facilities,
was calculated. The mean distance traveled to the LCS shop was strati-
ﬁed based on mode of transport (walking or motorized) and district.
Buffers were created around the LCS shops and health facilities to create
zones within a range of speciﬁed distances traveled. Buffers were over-
laid with the distribution of women of reproductive age to estimate the
proportion in each district who might have access to LCS and health
facilities. Although some LCS shops were located outside district
boundaries, and women from nearby districts might be served by
an LCS within the present study area, the analysis was restricted to
district boundaries.
The cost for women traveling to LCS shops to purchase DMPA from
any location in Amansie West was estimated by user self-report. A
cost analysis was not performed in Ejisu-Juabeng owing to the small
sample size. The analysis was conducted using inverse distanceweight-
ed interpolation, a geostatisticalmethod thatmodels costs at other loca-
tions using up to ﬁve known costs within a 10-km buffer, with the
closest known costs given the greatest weight [38]. In addition to total
costs, the model estimated ‘potential’ costs that might be incurred if
women could receive the DMPA injection from the LCS. For this scenar-
io, the cost of traveling to the health facility was removed, and the cost
of receiving the injection at the LCS shopwas assumed to be the same as
at the health facility.
3. Results
The distribution of health facilities and LCS shops in the two districts
is shown in Fig. 1. Users could purchase DMPA from 75 LCS shops in
Amansie West, with injections available at 22 health facilities. Likewise,
DMPAwas available at 29 LCS shops in Ejisu-Juabeng, with 13 health fa-
cilities providing injections. The proportion of women of reproductive
age within a given radius of an LCS shop was nearly always higher
than the proportion within the same radius of a health facility
(Table 1). For example, while 83.8% of women of reproductive age in
Fig. 1.Map showing the location of licensed chemical seller shops where depot medroxyprogesterone acetate (DMPA) was available for purchase and referral health facilities for DMPA
injections in the Amansie West and Ejisu-Juabeng districts of Ghana.
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purchased, only 58.5% were within 3 km of a health facility. In Ejisu-
Juabeng, access to LCS shops and health facilities was high and nearly
equal, 87.2% and 83.6% of women of reproductive age were within
3 km of these locations offering family planning services. The majority
of women of reproductive age in both districts lived within 5 km of an
LCS shop and a health facility.
The majority of women (n = 222; 74.5%) in both districts reported
walking to the LCS shopwhere they purchased DMPA, with the remain-
der usingmotorized transportation (data not shown). In AmansieWest,
21.1% of women of reproductive age lived within the average walking
distance among current users (1.21 km), compared with 80.4% within
the average driving distance of 2.85 km (Fig. 2). In Ejisu-Juabeng,
41.9% of women of reproductive age lived within the average walking
distance among current users (1.25 km), compared with 60.1% within
the average driving distance of 1.46 km (Fig. 3). Although the average
distance traveled to a health facility in Amansie West was shorter than
that in Ejisu-Juabeng (2.97 km vs 3.69 km), both were longer than the
average distance traveled to the LCS shop (1.61 and 1.27 km).Table 1
Women of reproductive age with access to health facilities and licensed chemical sellers
with depot medroxyprogesterone available for purchase in two districts of Ghana.a
Access radius Amansie West Ejisu-Juabeng
LCS shops Health facilities LCS shops Health facilities
Within 1 km 10.8 6.4 37.2 45.0
Within 2 km 60.1 24.8 71.2 68.2
Within 3 km 83.8 58.5 87.2 83.6
Within 4 km 89.5 77.9 92.0 88.8
Within 5 km 92.2 88.7 94.6 91.9
Abbreviation: LCS, licensed chemical seller.
a Values given as percentage.The average total cost incurred by women purchasing DMPA from
LCS in Amansie West and Ejisu-Juabeng was 2.59 cedis (US $1.30) and
3.19 cedis ($1.60), respectively. Most users (n = 274; 91.9%) felt that
the cost was acceptable (data not shown). If women could receive the
injection from the LCS instead of a health facility, then the average
cost incurred would be reduced to 1.97 cedis ($0.99) in Amansie West
and 2.44 cedis ($1.22) in Ejisu-Juabeng. These revised ﬁgures reﬂected
elimination of the costs associated with travel to the health facility.
An estimation of actual (total) and potential costs throughout
Amansie West showed how they varied across the district, primarily
as a result of transportation costs (Fig. 4). The highest costs occurred
in the southeast (a predominantly rural area), with the lowest costs
found across the central portion of the district, near major trading cen-
ters. Removing the cost of travel to the health facility reduced the size of
areas with above average costs.4. Discussion
Overall access to LCS shops that sold DMPA and health facilities that
could provide the injection was high in the Amansie West and Ejisu-
Juabeng districts of Ghana. If the average distance traveled to LCS
shops on foot was considered a proxy for the distance women were
willing to travel to purchase DMPA, the proportion of women of repro-
ductive age with access to DMPA from LCS shops was 21.1% in Amansie
West and 41.9% in Ejisu-Juabeng.
As LCS shops are ubiquitous throughout Ghana, the geospatial map-
ping conducted in the present study could provide a visual demonstra-
tion to policymakers that provision of DMPA by such shops has the
potential to dramatically increase access, especially in rural areas,
to the most popular method of family planning in Ghana. Of note,
women in the two regions analyzed traveled approximately twice the
distance to a health facility than to an LCS shop.
Fig. 2.Map showing areas with access to licensed chemical seller shops supplying depot medroxyprogesterone acetate in the Amansie West district of Ghana. In all, 21.1% of women of
reproductive age were within average walking distance and 80.4% were within average driving distance of a licensed chemical seller shop.
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shops showed variations by location, and the maps highlighted areas
where women in Amansie West were likely to be paying more than
the average for DMPA. Given that in 2008 the average annual income
per person in Ghana was 400 cedis [39], cost might be a limiting factor
formanywomen. Themaps generated in thepresent study could, there-
fore, offer a useful tool for policymakers focused on reducing costs in
these areas.
The present analysis showed how unmet need for family planning
in Ghana could be changed by altering the service provision modelFig. 3.Map showing areas with access to licensed chemical seller shops supplying depot medr
reproductive age were within average walking distance and 60.1% were within average drivinwith task-sharing. Further training could enable LCS to administer
DMPA injections; as a result, the geographic areas and proportion of
women of reproductive age with access to DMPA would increase
considerably. Substantial savings would also be made in cost, time,
and distance traveled.
Three simple requirements were necessary to perform the geospatial
analysis: geographic coordinates, interview data, and publically available
datasets. Even without ﬁeld collection of coordinates, Google Earth
(Google, Mountain View, CA, USA) and other programs allow such infor-
mation to be collected remotely. The family planning community shouldoxyprogesterone acetate in the Ejisu-Juabeng district of Ghana. In all, 41.9% of women of
g distance of a licensed chemical seller shop.
Fig. 4. Map outlining the estimated costs in Ghanaian cedis for depot medroxyprogesterone acetate across the Amansie West district of Ghana. Actual costs included depot
medroxyprogesterone acetate (DMPA), transport to the licensed chemical seller (LCS) shop and health facility, and the injection. Potential costs included DMPA, transport to the LCS
shop only, and the injection. Areas where estimated costs were expected to be above average, average, and below average are shown in red, yellow, and green, respectively. One
Ghanaian cedi is equivalent to approximately US $0.50.
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assess the demand and accessibility of services, and plan for geospatial
analysis in the early design stages.
The present study had several limitations. First, no user contact de-
tails were collected. As a result, the analysis was based on the LCS
shop where DMPA was purchased rather than on home addresses.
Such data would have eliminated the need for self-reported distances,
and allowed for increased accuracy in the estimates of the catchment
areas served by each LCS shop. Second, women were interviewed
from a subset of LCS shops. Consequently, the average distance traveled
was used rather than the speciﬁc distance for each LCS shop. A sampling
method that produced interview data from users at all LCS shops would
have allowed for more accurate mapping. Third, it was unknown what
women in this region viewed as an acceptable distance to travel to pur-
chase DMPA from an LCS shop or receive the injection from a health fa-
cility, and what costs were considered affordable. Although most users
stated the costwas acceptable, theywere not questioned about distance,
and itwas unknownhowmanywomendid not purchaseDMPAbecause
of prohibitive distances or cost. The present study used average distance
traveled bywomen to LCS shops as a proxy for acceptable distances, and
left interpretation of cost acceptability to policymakers. Finally, indirect
costs associated with travel, such as lost productivity, could not be
quantiﬁed. This information would have strengthened the argument
for the program’s impact.
In conclusion, the present study demonstrated that geospatial anal-
ysis could be a powerful tool to model program impact and provide in-
formation to decision-makers to help them understand complex issues.
Additionally, the maps created during this process were easily inter-
pretable as a visual reference. The maps showed that provision of
DMPA from LCS shops had the potential to increase access to this
family planning method in Ghana. By using GIS to understand issuesrelated to access and costs for women purchasing DMPA from LCS
shops, decision-makers might improve planning of future interventions
to maximize impact and meet the needs of women seeking family
planning resources.
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